Venclexta 100 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F20SU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,732
Award facts
- Contract value 100% obligated
- $20,732.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,732.18 to AmerisourceBergen Drug Corp for 120 tablets of Venclexta 100 mg on January 14, 2026, with an ultimate completion date of February 5, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Venclexta is a targeted cancer therapy used primarily in treating chronic lymphocytic leukemia and other blood cancers, indicating this delivery supports the Defense Health Agency's pharmaceutical supply chain for military treatment facilities and veterans' healthcare programs.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 31, 2031. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a wide range of medications, specialty drugs, vaccines, and medical supplies to support military healthcare operations worldwide. AmerisourceBergen's role as a major pharmaceutical distributor and the non-set-aside nature of this award reflect the company's demonstrated capability to compete successfully in federal medical procurement and meet critical supply needs for the Department of Defense and related healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F20SU?
SPE2DR26F20SU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F20SU worth?
The government has obligated $20,732 on SPE2DR26F20SU.
Is contract SPE2DR26F20SU an order under another contract?
Yes. SPE2DR26F20SU is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20SU competed?
The extent of competition for SPE2DR26F20SU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award